Clinical Trial Update: Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of continuous nocturnal apomorphine on sleep disturbances in Parkinson disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Apomorphine (apomorphine)

Snippet

Sponsor: Clinique Beau Soleil | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED